Navigation Links
Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
Date:3/25/2008

Furthers firm design and development efforts that focus on usability and

rapid commercialization

SAN FRANCISCO, March 25 /PRNewswire/ -- Hiemstra Product Development, an innovative, product design and development company, serving the life sciences industry, today announced the appointment of Daniel C. Rosenman as Vice President of Research & Development. As the company continues to expand, Dan furthers Hiemstra's commitment to the design and engineering of medical technologies that focus on usability and rapid commercialization.

Dan joins Hiemstra with over 16 years of R&D, operations, clinical, regulatory and quality systems experience in the life sciences industry. He has developed novel medical technologies in diverse clinical areas including general surgery, gynecology, orthopedics, urology, cardiac surgery, interventional cardiology, and ophthalmology, in both large companies and early-stage ventures. He began his life science career as an R&D engineer, specializing in bioabsorbable polymers, with Ethicon, Inc., a Johnson & Johnson company. Dan was one of the early employees at med tech start-ups, Heartport, Inc. and BioCardia, Inc., where he led the R&D efforts from the initial founding, to financing and through commercialization. Dan was the first employee at Transcend Medical, Inc., a venture-backed ophthalmic company. Within months of joining Transcend, he completed research, development and clinical milestones that resulted in series A funding. Dan holds over 27 U.S. patents in the medical field and has other global patents pending. He has co-authored several scientific and clinical publications in collaboration with clinical leaders at Stanford University, Massachusetts General Hospital, and HELIOS Hospital, Siegburg, Germany.

"My passion is to enable clients to develop their novel medical technologies for clinicians and, ultimately, patients," explains Rosenman. "At Hiemstra, our unique product development process delivers that. Our industrial and mechanical design teams are fully-integrated and focused on human factors that result in elegant solutions that go far beyond just clinical utility."

Doug Hiemstra, President, Hiemstra Product Development stated, "Dan adds tremendous value to our company and our customers. He brings a strong track record of successfully moving medical technologies from concept to development through commercialization."

About Hiemstra:

Hiemstra Product Development is an innovative medical product design and development company, serving the life sciences industry. Founded in 1991, this San Francisco-based firm is built on its unparalleled integration of industrial design and development, with a unique focus on usability. The company's production facilities provide for device assembly and rapid commercialization. Hiemstra's veteran team's experience spans a broad range of clinical areas and applications, and clients include start-ups to Fortune 500 companies. A description of services can be found at http://www.hiemstra.com.


'/>"/>
SOURCE Hiemstra Product Development
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hiemstra Approved to Manufacture Medical Devices in New CER
2. AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer
3. Digirad Corporation Appoints John W. Sayward to Its Board of Directors
4. NutraCea Appoints New Chief Financial Officer
5. Transplant Network Appoints Cynthia Siljestrom CEO
6. Solera Holdings, Inc. Appoints Jason Brady as General Counsel
7. The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer
8. InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
9. Ventas Appoints James D. Shelton and Robert D. Reed to Board
10. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
11. China Sky One Medical, Inc. Appoints Four Independent Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... for customers and employees that are both engaging and easy to use. Coming ... Technology, the software company revealed today its plans to roll out new AI-powered ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... set up in 2006 as a non-profit organization to unite pharmaceutical and healthcare ...
(Date:12/8/2016)... ... ... STAT courier is pleased to announce that due to customer demand, as ... their presence in Dallas. One of the most exciting parts for STAT is that ... Dallas and Forth Worth market. STAT takes pride in treating their employees with integrity ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... the global optical transceiver market to grow at a CAGR of ... the present scenario and the growth prospects of the global optical ... considers the revenue generated from the shipment of optical transceivers worldwide ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology: